Barclays Has Lowered Expectations for Owens & Minor (NYSE:OMI) Stock Price

Owens & Minor (NYSE:OMI) had its price objective decreased by Barclays from $18.00 to $14.00 in a research note released on Tuesday morning,Benzinga reports. Barclays currently has an equal weight rating on the stock.

Several other analysts also recently weighed in on OMI. JPMorgan Chase & Co. cut their price objective on shares of Owens & Minor from $22.00 to $18.00 and set an “underweight” rating on the stock in a research report on Wednesday, August 21st. StockNews.com downgraded shares of Owens & Minor from a “buy” rating to a “hold” rating in a research report on Monday, August 26th. Citigroup raised shares of Owens & Minor from a “neutral” rating to a “buy” rating and reduced their price target for the stock from $24.00 to $19.00 in a research report on Friday, July 19th. Finally, Robert W. Baird dropped their price objective on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating on the stock in a research note on Tuesday. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $18.50.

Owens & Minor Stock Down 1.8 %

OMI stock traded down $0.23 during mid-day trading on Tuesday, hitting $12.53. 25,801 shares of the company were exchanged, compared to its average volume of 834,575. The company has a market capitalization of $966.01 million, a PE ratio of -19.63, a price-to-earnings-growth ratio of 0.39 and a beta of 0.41. The company has a current ratio of 1.09, a quick ratio of 0.51 and a debt-to-equity ratio of 2.11. Owens & Minor has a twelve month low of $11.42 and a twelve month high of $28.35. The firm has a fifty day simple moving average of $14.35 and a 200 day simple moving average of $16.06.

Owens & Minor (NYSE:OMI) last posted its quarterly earnings results on Monday, November 4th. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.41 by $0.01. The business had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The company’s quarterly revenue was up 5.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.44 EPS. On average, research analysts forecast that Owens & Minor will post 1.55 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Owens & Minor

Institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in Owens & Minor by 1.9% during the first quarter. Vanguard Group Inc. now owns 8,749,866 shares of the company’s stock valued at $242,459,000 after acquiring an additional 162,182 shares during the period. Deerfield Management Company L.P. Series C increased its stake in Owens & Minor by 30.6% during the second quarter. Deerfield Management Company L.P. Series C now owns 6,371,440 shares of the company’s stock valued at $86,014,000 after acquiring an additional 1,493,852 shares during the period. Renaissance Technologies LLC increased its stake in Owens & Minor by 16.5% during the second quarter. Renaissance Technologies LLC now owns 1,246,600 shares of the company’s stock valued at $16,829,000 after acquiring an additional 176,250 shares during the period. Gabelli Funds LLC increased its stake in Owens & Minor by 25.9% during the first quarter. Gabelli Funds LLC now owns 170,000 shares of the company’s stock valued at $4,711,000 after acquiring an additional 35,000 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in Owens & Minor by 1.7% during the second quarter. Dimensional Fund Advisors LP now owns 4,534,204 shares of the company’s stock valued at $61,213,000 after acquiring an additional 76,599 shares during the period. 98.04% of the stock is currently owned by institutional investors.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.